Millipore Opens New State-of-the-Art Manufacturing Facility
Millipore Corporation announced the official opening of its new $29 million state-of-the-art membrane casting manufacturing facility in Jaffrey, New Hampshire. Adjacent to Millipore's current device plant on Prescott Road, the 44,000-square-foot building will enable Millipore to increase production of its ultrafiltration (UF) membranes for worldwide biopharmaceutical markets.
Today, more than 400 local employees as well as state and local officials joined Millipore executives to celebrate the milestone. Governor Craig Benson participated in the ribbon cutting ceremony with opening remarks.
"For the past 30 years, Millipore has been a very strong corporate citizen in New Hampshire," said Craig Benson, Governor of the State of New Hampshire. "This new facility represents not only Millipore's investment in the state, but also the foundation of future biotechnology growth."
Aligned with Millipore's commitment to providing the highest level of quality, the membrane plant houses an advanced Class 100,000 controlled environment and state-of-the-art manufacturing equipment. A new wastewater pretreatment plant is located next to the new facility. In addition, a 33,000-square-foot warehouse is currently under construction to connect the new membrane manufacturing facility to the company's device plant. All equipment and processes in the new facility are cGMP compliant to meet the pharmaceutical industry's regulatory standards.
"The Jaffrey opening will enable us to meet the growing worldwide demand for ultrafiltration membrane and devices over the next decade," said Pete Kershaw, Vice President of Worldwide Manufacturing Operations for Millipore. "Major biotech customers were involved in the planning of this new facility to help ensure alignment with the highest standards demanded by the industry we serve."
Most read news
Organizations
Other news from the department manufacturing
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Fluorotechnics appoints James Walker CEO - Duncan Veal appointed to key role of chief technology officer
Varian, Inc. Completes Electronics Manufacturing Divestiture - Varian, Inc. to Focus Efforts on Scientific Instruments and Vacuum Technologies Businesses
Hazardous ingredients in batteries - Trust, but verify! A long and winding road to an innovative method
JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
Ring of complex organic molecules around newborn star discovered
Researchers discover new genetic mutation that causes male infertility
Exonhit presents new opportunities in blood diagnostics in neurodegenerative diseases - Identification of new markers for BSE in collaboration with Roche Applied Science
Wanted: The faces of the chemical crowd